clinical trial · NCT04855955
Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer's Disease
Alzheimer DiseaseAdipose-Derived Mesenchymal Stem Cells
brief summary
This is a single patient emergency expanded access clinical study to assess the safety of administering autologous AdMSCs to an incurable Alzheimer disease patient. The study subject will be evaluated for disease-associated severity according to symptoms, cognitive function, memory, and quality of life.
started
—
primary completion
—
completion
—
last updated
Feb 7, 2024
official title
Individual Patient Expanded Access Investigation New Drug (IND) Application for Administration of Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer's Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol